Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Oppenheim H. About a rare spasm disease of childhood and young age (Dysbasia lordotica progressiva, dystonia musculorum deformans). Neurologische Centralblatt. 1911;30:1090–107.
Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863–73.
Fahn S. Concept and classification of dystonia. Adv Neurol. 1988;50:1–8.
Sanger TD. Pathophysiology of pediatric movement disorders. J Child Neurol. 2003;18(Suppl 1):S9–S24.
Mink JW. Special concerns in defining, studying, and treating dystonia in children. Mov Disord. 2013;28:921–5.
Calado R, Monteiro JP, Fonseca MJ. Transient idiopathic dystonia in infancy. Acta Paediatr. 2011;100:624–7.
Himmelmann K, McManus V, Hagberg G, et al. SCPE collaboration. Dyskinetic cerebral palsy in Europe: trends in prevalence and severity. Arch Dis Child. 2009;94:921–6.
Misra UK, Kalita J. Spectrum of movement disorders in encephalitis. J Neurol. 2010;257:2052–8.
Donaldson IM, Marsden CD, Schneider SA, et al. Marsden’s book of movement disorders. Oxford: Oxford University Press; 2012.
Singer HS, Jankovic J, Mink JW, et al. Movement disorders in childhood. Philadelphia: Saunders Elsevier; 2010.
Gulati S, Sondhi V, Chakrabarty B, Prashant Jauhari RD. Autoimmune encephalitis in children: clinical profile and outcome from a single tertiary care Centre in India. Neurology. 2018;90(15):P2.313.
Rubio-Agusti I, Dalmau J, Sevilla T, Burgal M, Beltran E, Bataller L. Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord. 2011;26:351–2.
Mohammad SS, Fung VS, Grattan-Smith P, Gill D, Pillai S, Ramanathan S, et al. Movement disorders in children with anti- NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord. 2014a;29:1539–42.
Doummar D, Roussat B, Beauvais P, Billette de Villemeur T, Richardet JM. Spasmus nutans: apropos of 16 cases. Arch Pediatr. 1998;5:264–8.
Olguner M, Akgur FM, Hakguder G, et al. Gastroesophageal reflux associated with dystonic movements: Sandifer’s syndrome. Pediatr Int. 1999;41(3):321–2.
Ashalatha R, Kishore A, Sarada C, Nair MD. Satoyoshi syndrome. Neurol India. 2004;52:94–5.
Klein C. Genetics in dystonia. Parkinsonism Relat Disord. 2014;20(Suppl 1):S137–42.
Monbaliu E, De Cock P, Ortibus E, Heyrman L, Klingels K, Feys H. Clinical patterns of dystonia and choreoathetosis in participants with dyskinetic cerebral palsy. Dev Med Child Neurol. 2016;58:138–44.
Iafolla AK, Kahler SG. Megaloencephaly in the neonatal period as the initial manifestation of glutaric aciduria type I. J Pediatr. 1989;114:1004–6.
Hoffmann GF, Athanassopoulos S, Burlina AB, et al. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 1996;27:115–23.
Jinnah HA, De Gregorio L, Harris JC, et al. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res. 2000;463:309–26.
Ozelius L, Lubarr N. DYT1 early-onset isolated dystonia. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. . Seattle (WA): GeneReviews((R)); 1993.
Bruggemann N, Kuhn A, Schneider SA, et al. Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology. 2015;84:895–903.
Tadic V, Kasten M, Bruggemann N, et al. Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Arch Neurol. 2012;69:1558–62.
Roubertie A, Mariani LL, Fernandez-Alvarez E, et al. Treatment for dystonia in childhood. Eur J Neurol. 2012;19:1292–9.
Thenganatt MA, Jankovic J. Treatment of dystonia. Neurotherapeutics. 2014;11:139–52.
Albanese A, Asmus F, Bhatia KP, et al. EFNS guidelines on diagnosis and treatment of primary dystonias. Eur J Neurol. 2011;18(1):5–18.
Borggraefe I, Mehrkens JH, Telegravciska M, et al. Bi- lateral pallidal stimulation in children and adolescents with primary generalized dystonia–report of six patients and literature-based analysis of predictive outcomes variables. Brain and Development. 2010;32(3):223–8.
Comella CL, Pullman SL. Botulinum Toxin in neurological disease. Muscle Nerve. 2004;29:628–44.
Tintner R, Jankovic J. Botulinum toxin. In: Warner TT, Bressman SB, editors. Clinical diagnosis and management of dystonia. Informa Press; 2007. p. 188–207.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Chouksey, A., Pandey, S. (2024). Childhood Dystonia. In: Oli, K.K., Shrestha, G.S., Ojha, R., Pal, P.K., Pandey, S., Das, B. (eds) Case-based Approach to Common Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-8676-7_27
Download citation
DOI: https://doi.org/10.1007/978-981-99-8676-7_27
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8675-0
Online ISBN: 978-981-99-8676-7
eBook Packages: MedicineMedicine (R0)